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Abstract
Background: Bone marrow stromal cells (BMSCs) are pluripotent and thereby a potential candidate for cell replacement
therapy for central nervous system degenerative disorders and traumatic injury. However, the mechanism of their
differentiation and effect on neural tissues has not been fully elucidated. This study evaluates the effect of BMSCs on neural
cell growth and survival in a retinal ganglion cell (RGCs) model by assessing the effect of changes in the expression of a
BMSC-secreted protein, thrombospondin-1 (TSP-1), as a putative mechanistic agent acting on RGCs.
Methods and Findings: The effect of co-culturing BMSCs and RGCs in vitro was evaluated by measuring the following
parameters: neurite outgrowth, RGC survival, BMSC neural-like differentiation, and the effect of TSP-1 on both cell lines under
basal secretion conditions and when TSP-1 expression was inhibited. Our data show that BMSCs improved RGC survival and
neurite outgrowth. Synaptophysin, MAP-2, and TGF-b expression are up-regulated in RGCs co-cultured with BMSCs.
Interestingly, the BMSCs progressively displayed neural-like morphology over the seven-day study period. Restriction display
polymerase chain reaction (RD-PCR) was performed to screen for differentially expressed genes in BMSCs cultured alone or co-
cultured with RGCs. TSP-1, a multifactorial extracellular matrix protein, is critically important in the formation of neural
connections during development, so its function in our co-culture model was investigated by small interfering RNA (siRNA)
transfection. When TSP-1 expression was decreased with siRNA silencing, BMSCs had no impact on RGC survival, but reduced
neurite outgrowth and decreased expression of synaptophysin, MAP-2 and TGF-b in RGCs. Furthermore, the number of BMSCs
with neural-like characteristics was significantly decreased by more than two-fold using siRNA silencing.
Conclusions: Our data suggest that the TSP-1 signaling pathway might have an important role in neural-like differentiation
in BMSCs and neurite outgrowth in RGCs. This study provides new insights into the potential reparative mechanisms of
neural cell repair.
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Introduction
BMSCs can self-renew,proliferate, and/or differentiate into a
variety of cell types, such as cardiomyocytes, rhabdomyocytes,
hepatocytes, osteocytes, chondrocytes, tencoytes, adipocytes,
smooth muscle cells, and possibly even neural cells [1–6].
Therefore, BMSCs could play an important role in tissue repair
by replacement of lost cells and stimulation of reparative processes
within injured tissues [7]. For example, transplantation of BMSCs
can improve functional recovery after stroke or other neurological
trauma in animals [8–11]. Additionally, clinical trials with BMSCs
are ongoing, and other clinical studies have been proposed to
elucidate their usefulness [6,12–16]. Koc and colleagues conclud-
ed that patients with Hurler syndrome and metachromatic
leukodystrophy, both associated with skeletal muscle and neuro-
logical manifestations, might experience a reversal of disease
pathology in some tissues treated with allogeneic BMSC infusion
[13]. Additionally, Osiris, Inc. (Baltimore, MD) has been granted
‘‘Fast Track’’ designation from the United States Food and Drug
Administration; patients who have undergone bone marrow
transplantation and experiencing graft-versus-host disease are
being enrolled into a Phase III trial [16].
Some researchers, including our group, have reported that
BMSCs can differentiate into neural-like cells, with the expression
of neural-associated proteins in vivo and in vitro [17–23]. For
example, we reported that BMSCs can express NF and MAP-2
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cell conditioned medium, or when co-cultured with neonatal rat
retinal ganglion cells. However, the criteria for judging such
transdifferentiation have been incomplete in many studies, often
relying on genetic expression studies and morphological changes,
rather than definitive proof of neuron-like characteristics such as
synapse formation and appropriate electrophysiological properties.
Conversely, several studies have demonstrated little or no neural
differentiation in vivo after BMSC transplantation, although
functional recovery appeared improved [24–29]. Still, based on
additional observations, some investigators support the hypothesis
that BMSCs secrete factors that promote neural recovery and
survival. For example, BMSC treatment in an experimentally-
induced ischemic stroke rat model facilitated axonal sprouting and
remyelination in the cortical ischemic boundary zone and corpus
callosum, which might have accounted for the neurological
functional improvement observed [30,31]. Intravenously admin-
istered BMSCs from male rats increased basic fibroblast growth
factor expression, reduced apoptosis, promoted endogenous
cellular proliferation, and improved functional recovery after
ischemic stroke in female rats [32–34].
In order to elucidate the underlying reparative mechanisms,
BMSCs and RGCs were co-cultured to evaluate for morphological
changes. Additionally, RD-PCR was performed to detect
differentially expressed BMSC genes when BMSCs were co-
cultured with RGCs versus BMSCs cultured alone. Our data show
that BMSCs and RGCs affect each other when co-cultured in vitro,
resulting in BMSCs progressively displaying neural-like features
over the seven-day study period, which is not likely achievable
with simple chemical treatments [17]. Also, RGC survival and
neurite outgrowth were improved. Synaptophysin, MAP-2 and
TGF-b expression were up-regulated in RGCs co-cultured with
BMSCs compared to RGCs cultured alone.
Interestingly, we found that TSP-1, an extracellular matrix
glycoprotein with a variety of functions and best known for its
antiangiogenic properties, was up-regulated in BMSCs co-cultured
with RGCs compared to BMSCs cultured alone. TSP-1 is
critically important in the formation of neural connections during
development [35-37]. TSP-1 is highly expressed in the early
postnatal rat cortex and superior colliculus during the period of
intense synaptogenesis, but levels progressively decline as juvenile
rats mature into adults. Immunocytochemical analysis revealed a
25–40% decrease in the density of synaptic puncta in the cortices
of postnatal P8 and P21 mice lacking TSP-1 [38]. Therefore, we
sought to investigate whether TSP-1 expression by BMSCs plays a
role in neurite outgrowth of RGCs by co-culturing them with
BMSCs. In order to evaluate the role of TSP-1, double siRNA
transfection was used to transiently and selectively decrease
endogenous expression of TSP-1. Silencing of TSP-1 with siRNA
in BMSCs did not affect survival but reduced neurite outgrowth
and expression of synaptophysin, MAP-2, and TGF-b in RGCs.
Also, the number of neural-like BMSCs was significantly decreased
by more than two-fold. Therefore, our data suggest that BMSCs
and RGCs affect each other when co-cultured in vitro. The TSP-1
signaling pathway may play an important role in BMSC neural-
like morphological change. We are unaware of any other study
describing that BMSC-derived TSP-1 enhances RGC neurite
formation, survival, and expression of synaptophysin, MAP-2, and
TGF-b. Other researchers have shown that TSP-1 is involved in
the healing process by suppressing inflammation which may result
after an acute injury such as a wound or infarct. For example,
Chatila and colleagues concluded that TSP-1 plays a critically
important role after a myocardial infarct by limiting the expansion
of fibrosis into the non-infarcted surrounding myocardium [39],
while Uno and colleagues have suggested that TSP-1 accelerates
corneal wound healing [40–42]. This study provides new insights
on BMSC-mediated neuronal plasticity and the putative role of
TSP-1 as a specific mediator of reparative processes in neurons.
Materials and Methods
Cell Culture
Primary BMSC culture. BMSCs were isolated by previously
described methods. We utilized a well characterized technique that
has been previously used by our lab (21, 22) and multiple others
[17,43].. Briefly, adult female Sprague Dawley rats (n=5, 200–
250 g body weight) were sacrificed by an intraperitoneal injection of
Nembutal (60 mg/kg) (P3761, Sigma, St. Louis, MO). The tibias
and femurs were extracted aseptically and rinsed with cold
phosphate buffered saline (PBS, pH 7.4). A sterile 18-gauge needle
was inserted into each bone marrow (BM) cavity, and the BM was
extruded by injecting 10 ml of cold Dulbecco’s Modified Eagle
Medium (DMEM). The extruded BM was filtered through a 70-mm
cell strainer (BD Biosciences, Bedford, MA) and centrifuged at
1200 rpm for 5 min. The BM pellet was resuspended in a flask
containingDMEM,supplementedwith10%inactivatedfetalbovine
serum (FBS), 2 mM glutamine, 100 U/ml penicillin, and 100 mg/
ml streptomycin. The culture medium was replaced to remove non-
adherent cells after plating the cells for 24 hr. When the cells had
grown to near confluency, passages of the cells were performed using
0.25% trypsin/1 mM EDTA. After 3–4 passages, the cells were
stained with rabbit anti-rat IgG monoclonal antibodies CD44,
CD71, CD106, and CD45 diluted 1:100 (sc-9099, sc-25590, Santa
Cruz Biotechnology, Santa Cruz, CA, BA0321, BA0406, Boster
Biological Technology, Wuhan China). The BMSCs were used
before the 6th passage, because they undergo morphological and
functional changes after 10 passages that make them unsuitable for
this type of experimentation.
Primary rat RGC cultures. RGCs were purified by
sequential immunopanning to .99.5% purity from Sprague
Dawley rats by previously described methods [44,45]. Briefly,
four 3-day-old Sprague Dawley rats were sacrificed by an
intraperitoneal injection of Nembutal (P3761, 60 mg/kg) (Sigma,
St. Louis, MO) and approximately 8 eyes were harvested for each
experiment. The retinas that were separated from the enucleated
eyeballs were incubated for 20 min in a solution containing 0.25%
trypsin to dissociate the cells, followed by a 5 min incubation with
mouse anti-macrophage monoclonal IgG diluted 1:100 in
antibody medium (sc-66204, Santa Cruz Biotechnology, Santa
Cruz, CA). The cell suspensions were then incubated for 30 min
on a 100-mm diameter petri dish coated with goat anti-mouse
monoclonal IgG diluted 1:100 in antibody medium (Santa Cruz
Biotechnology, Santa Cruz, CA). Suspensions containing cells that
did not adhere to the petri dish were collected and incubated for
1 hr on a 100-mm diameter petri dish coated with anti-Thy-1.1
monoclonal IgG diluted 1:100 in antibody medium (sc-53116,
Santa Cruz Biotechnology, Santa Cruz, CA). The cells that
adhered to this pretri dish were released enzymatically (trypsin
0.125% for 10 min), after which they were cultured in 6-well
plates coated with 0.1 mg/ml polylysine (P1399, Sigma, St. Louis,
MO) in DMEM supplemented with 10% FBS and 25 uM
glutamate (G0400, Sigma, St. Louis, MO) at 37uCi na n
atmosphere of 5% CO2 and 95% air with humidity. In order to
assess the purity of RGCs, the cells were cultured in medium. After
3 days, FACS was performed to test the RGCs purity with a RGC
specific antibody, FITC labelled Thy1.1. Briefly, 1610
6 cells/ml
were harvested in PBS (10% FCS, 1% sodium azide), then
incubated in 5 mg/ml of the FITC labeled Thy1.1 antibody
TSP-1, BMSCs, RGCs
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temperature. For the control, the cells were incubated with PBS.
2.5 mg/ml 7-AAD was added at this point for dead cell exclusion.
Thecellswere washed three times by centrifugation at 400 rpm for 5
minutes and then resuspended in 500 ul ice cold PBS (10% FCS,1%
sodium azide). FACS was performed to access the purity of RGCs.
Assay of BMSC and RGC survival and neurite
outgrowth. 2610
5 BMSCs and RGCs were co-cultured in a
transwell system (0.45-uM pore size; BD Bioscience, Bedford, MA)
in complete medium. After 5 days, the cover slips were fixed for
7 min in 4% paraformaldehyde, washed 3 times with PBS, and
then incubated with 0.1% DAPI for 5 min. Following incubation,
the cover slips were washed five times in PBS and mounted in
Vectashield mounting medium on glass slides. Under fluorescent
microscopy, 10 pictures were randomly taken from one slide in
106 microscopic fields. Cells with an intact nucleus were
considered viable. For neurite outgrowth of RGCs, 10 pictures
were taken randomly under a regular microscope from one slide.
The neurite outgrowth of RGCs was assessed with a camera-
lucida projection onto concentric circles. Outgrowth was
determined by summing the lengths of all the cells and dividing
by the total number of cells in 106 microscopic fields. The
percentages of surviving and outgrowth of RGCs were determined
on two or three cover slips for each experimental condition and
normalized to the control cells examined in a similar manner. The
average relative percent of surviving and outgrowth of RGCs
from at least three separate experiments for each experimental
condition is expressed in the text and figures as the mean+/2S.D.
RD-PCR assay. BMSCs and RGCs were co-cultured in
complete medium in the transwell system described above. After 3
days, the total RNA, from the experimental and control condi-
tions, respectively, was isolated with TRIzol Reagent (10296010,
Invitrogen, Carlsbad, CA). RD-PCR was performed by previously
described methods [46,47]. Briefly, the cDNAs were synthesized
with a cDNA kit (D2620, Takara, Dalian China). The cDNAs
were digested at 37uC for 3 h in a mixture of 2 uL Sau3A1(10 U/
uL ) (59GATC39) (D1082A, Takara, Dalian China) in total volume
20 uL of mixture. The two ends of each Sau3A1-digested
fragment were linked to an adapter prepared by annealing the 2
oligonucleotides containing 59-GATCCACACCAGCCAAACC-
CA-39 (SIP) and 59-GGTTTGGCTGGTGTG-39 (SIR) in a
ligation reaction containing 1 uL T4 DNA ligase (350 U/uL)
(EL0011, Fermentas, Burlington Canada), 1 uL 106DNA ligation
buffer, 1 uL adapter (50 umol/L), and 20 pmol of Sau3A1-
digested BMSC cDNA fragments; then, sterile water was added
to make the final volume 10 uL. After 4 h of ligation at 16uC,
PCR was performed in a 9700 thermocycler (Applied Biosystems,
Foster City, CA) with the initial denaturation at 94uC for 5 min,
followed by 35 cycles each at 94uC for 30 s, 60uC for 30 s, 72uC
for 1 min, and a final extension at 72uC for 10 min. The PCR
primers were designed to match the universal adapters, including
the restriction site sequence, but with one ‘‘nesting’’ base
overhanging the 39-end. The reactions were divided into 10
subgroups [46,47]. To evaluate the success of our RD-PCR, 7 uL
of the PCR products were loaded onto 5% polyacrylamide gel to
perform eletrophoresis at 90 V for 5–6 h followed by silver
staining to separate different gene fragments.
The differentially expressed gene fragments or expressed
sequence tags (EST) were isolated from the gel, and a second
PCR was performed to investigate a band’s contents. The PCR
products were ligated with pMD-18-T Vector (D101C, Takara,
Dalian China), and then sequenced with pMD-18-T sequencing
primers. A BLAST search was performed on the EST sequences
(http://www.ncbi.nlm.nih.gov/BLAST/Blast). The levels of
mRNA and protein homologues for the EST were measured by
semi-quantitative reverse transcriptase polymerase chain reaction
(RT-PCR) and Western blot analysis, respectively.
Semi-quantitative RT-PCR and Western blot
analysis. Total RNA was isolated with TRIzol Reagent. RT-
PCR was performed using the one-step RT-PCR system (A1250,
Promega, Madison, WI). The primer TSP-1 A (sense) is
59GTTGCATGTGTGTGGAAGCAAC39, and the primer TSP-
1 B (antisense) is 59ACCACACTGAAGATCTGGCCAG39. The
primer beta-actin A (sense) is 59GATATCGCTGCGCTCGT-
CGTCG39, and the primer beta-actin B (antisense) is 59CGAC-
GACGAGCGCAGCGATATC39. For TSP-1, RT-PCR was
performed for 35 cycles each at 94uC for 30 s, 60uC for 30 s,
72uC for 1 min, and a final extension at 72uC for 10 min. RT-
PCR for beta-actin was performed for 20 cycles, each with the
same temperature and time parameters as for TSP-1. Western blot
analysis was performed by previously described methods [48]. The
following IgG monoclonal antibodies were used: mouse anti-TSP-
1 diluted 1:1000 (BA24, Oncogene, San Diego, CA), rabbit anti-
myc diluted 1:1000 (sc-788, Santa Cruz Biotechnology, Santa
Cruz, CA), and mouse anti-actin diluted 1:1000 (sc-69879, Santa
Cruz Biotechnology, Santa Cruz, CA). Proteins were visualized
with horseradish peroxidase (HRP)-conjugated anti-rabbit, anti-
mouse IgG diluted 1:5000 (sc2004, Santa Cruz Biotechnology,
sc2005, Santa Cruz, CA), followed by use of the ECL (HRP)
Western blot analysis system (Santa Cruz Biotechnology, Santa
Cruz, CA).
Measurement of TSP1 in co-culture medium by Western
blot. 1610
6 BMSCs and RGCs were co-cultured in a transwell
system (0.45-uM pore size; BD Bioscience, Bedford, MA) in
complete medium. After 24 hours, the medium was replaced with
10 ml of serum-free medium and the cells were incubated for 24
hours. The conditioned medium was collected, concentrated with
a Centricon-10 (UFC910024, Billerica, MA), and protein
concentrations were determined with the BCA assay (#23250,
Pierce, Rockford, IL). Twenty mg of total protein was subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis; after
electrophoresis the proteins were transferred to a nitrocellulose
membrane. Western blot analysis was performed by described
methods above.
RNA interference (or silencing). The siRNA sequences
used for targeted silencing of TSP-1 expression and the control
sequences were as follows: #TSP-1, GUUGGCACAAAGGCU-
CCA dTdT and #control, GGUUUGGCUGGGGUGUUA-
UdTdT. The oligos were purchased from Dharmacon (Lafayette,
CO). Transfection of siRNA was performed using oligofectamine
2000 (11668-019, Invitrogen, Carlsbad, CA). Transfection was
performed twice, 24 hours apart, to enhance the success of siRNA
silencing. As a rescue experiment, some BMSCs were transduced at
the second siRNA transfection with a recombinant adenovirus
(pAd/CMV-Myc-TSP-1) expressing TSP-1, a fusion protein, and
Myc-TSP-1. The TSP-1 cDNA sequence in the pAd/CMV-Myc-
TSP-1 adenovirus expresses the same amino acids as BMSC-derived
TSP-1 from rats but with different codons, thus these cDNA
sequences are resistant to siRNA silencing. Expression levels of TSP-
1 were measured by Western blot analysis on the third day
Effect of TSP-1 on BMSCs and RGCs. BMSCs were
transfected with TSP-1 siRNA, and if rescued, they were then
transduced with the TSP-1-expressing recombinant adenovirus as
previously described. 48 hours after the first siRNA transfection,
the cells were washed twice with sterile PBS. Trypsin buffer
0.125% was added to the petri dish and incubated at 37uC for
3 min. Trypsin digestion was inhibited by the addition of complete
medium. Then, the BMSCs and RGCs were co-cultured in
TSP-1, BMSCs, RGCs
PLoS ONE | www.plosone.org 3 June 2008 | Volume 3 | Issue 6 | e2470complete medium in the transwell system described above. After 3
and 5 days, an assessment of RGC survival and neurite outgrowth
was performed as described above.
Synatophysin expression in RGCs. BMSCs were
transfected with TSP-1 siRNA, and if rescued, they were then
transduced with the TSP-1-expressing recombinant adenovirus as
described previously. 48 hours after the first siRNA transfection,
the cells were washed twice with sterile PBS. Trypsin buffer
0.125% was added to the petri dish and incubated at 37uC for
3 min. Trypsin digestion was inhibited by the addition of complete
medium. The BMSCs and RGCs were then co-cultured in
complete medium in the transwell system described above. After 3
days, RGCs were fixed for 7 min in 4% paraformaldehyde (PFA),
washed three times in PBS, and blocked for 30 min in 100 uL of a
blocking buffer containing 0.1% Triton X-100. After blocking, the
cover slips were washed three times in PBS, and 100 uL of mouse
anti-synaptophysin (BM0125, Boster Biological Technology,
Wuhan China), diluted 1:100 in antibody buffer, was added to
each cover slip. For the control, the cover slips were incubated
with PBS. The cover slips were then incubated overnight at 4uC,
washed three times in PBS, and incubated for 2 hr with 100 uL of
Cy3 conjugated sheep anti-mouse (BA1031, Bios, Beijing China),
diluted 1:50 in antibody buffer. Following incubation, the cover
slips were washed five times in PBS and mounted in Vectashield
mounting medium on glass slides. The pictures were taken by laser
scan confocol microscopy (LSM 510 Meta, Zeiss, Germany).
Western blot analysis was performed as described above.
Real-time RT-PCR. Total RNA was isolated with TRIzol
Reagent (10296010, Invitrogen, Carlsbad, CA). One microgram of
total RNA was subjected to reverse transcription with the SYBR
PrimeScriptTM RT-PCR kit (DRR063S,Takara, Dalian China)
following the manufactures protocol. Real-time PCR was employed
to measure TSP-1, TSP-2, CD36, CD47, TGF-b,M A P - 2 ,
synaptophysin expression using the SYBR Green system
(DRR063S,Takara, Dalian, China). The primers are displayed in
Table 1. The thermal cycling conditions comprised an initial
denaturationstepat 95 uC for3 min,then 40cyclesoftwo-stepPCR
including 95uC for 15 s and 60uC for 30 s. Data were collected
during the 60uC. The amount of target gene mRNA relative to the
internal control gene, b-actin, was calculated using the DCT method
as follows: the relative expression=2
2DCT, DCT=CT(target
gene)2CT(b-actin ) [49]. The data were analyzed in triplicate.
Statistical Analysis. Data are expressed as means+/2SE.
The differences between mean values were evaluated with the two-
tailed Student’s t-test (for 2 groups) and the analysis of variance
(ANOVA, for .2 groups). All calculations and statistical tests were
performed by the computer programs Microsoft Excel 2003
(Microsoft, Redmond, WA) or SPSS 11.5 (SPSS, Chicago, IL).
p,0.05 was considered significant for all analyses.
Results
BMSC neural differentiation and their effect on RGCs
survival and outgrowth
After BMSCs were co-cultured with RGCs, changes in BMSC
morphology were observed after the first day (Figure 1A). Initially,
the cytoplasm in the BMSCs retracted toward the nucleus and the
Table 1. The primers Real-time RT-PCR.
TSP-1 Sense 59-GCCAGATGACAAGTTCCAAG-39
Antisense 59-CTGACACCACTTGCTGCTTC-39
TSP-2: Sense 59-AGTGGAGACAGGATGCTCTG-39
Antisense 59-GGACGTAGTCAAACCGGACA-39
CD36 Sense 59-GTCTTCTATGTTCCAAACAC-39
Antisense 59-TATAAACTGGATCTACAGTG-39
CD47 Sense 59-ACTCAAATACAAGTCCAGCC-39
Antisense 59-CAAGACCAGAAGCGTTCTTC-39
TGF-b Sense 59-TGCTTCAGCTCCACAGAGAA-39
Antisense 59-TGGTTGTAGAGGGCAAGGAC-39
Map-2 Sense 59-ACCTGCCTGAGATGCTAGAT-39
Antisense 59-TGTCATCAGCAACAGGTGGC-39
Synaptophysin Sense 59- GTGTACTTTGATGCACCCTC -39
Antisense 59- TCTGCAGGAAGATGTAGGTG -39
doi:10.1371/journal.pone.0002470.t001
Figure 1. The morphology of the BMSCs after co-culturing. A, The morphological changes of BMSCs over 7 days (106); B, The bar graph
demonstrates that the percentage of neural-like BMSCs increases when co-cultured with RGCs. p#0.05 at all time points. (10 pictures were taken
randomly under a regular microscope from culturing cells at different time points. The average relative percent of neural-like BMSCs come from at
least three separate experiments).
doi:10.1371/journal.pone.0002470.g001
TSP-1, BMSCs, RGCs
PLoS ONE | www.plosone.org 4 June 2008 | Volume 3 | Issue 6 | e2470cell bodies became more rounded. Cells continued along this
progression with eventual neurite-like outgrowth, displaying
primary and secondary branching. Over the subsequent 7 days,
92.2% (p=0.026) of the BMSCs had a similar morphology
(Figure 1B), while the remaining 7.8% of BMSCs had nonspecific
morphological changes (p=0.031). However, after 15 days of co-
culturing with RGCs, BMSCs gradually died.
Phase contrast photographs ((Figure 2A) were taken from one
well each containing RGCs cultured alone (control) and RGCs co-
cultured with BMSCs (experimental group). BMSCs not only
promoted RGC survival, but also significantly increased the
formation of fine neurites with branching cones in RGCs
compared to controls. According to our counting strategy, co-
culturing of RGCs with BMSCs yielded a survival increase of up to
1.7-fold (Figure 2C), and more than 70% of RGCs had intact
neurites after 5 days of co-culturing, compared to RGC controls
with only 8.2% (p=0.021). Figure 2D shows that BMSCs had a
significant effect on neurite outgrowth of RGCs by increasing the
number of primary and secondary branches. Real-time RT-PCR
data showed that synaptophysin, MAP-2 and TGF-b expression
were up-regulated in RGCs co-cultured with BMSCs as compared
to RGCs cultured alone (Figure 2B).
TSP-1 is up-regulated in BMSCs co-cultured with RGCs
To assay mRNA expression profiles which might account for
the observed morphological changes when BMSCs are co-
cultured with RGCs, RD-PCR was performed with BMSCs
cultured alone and with RGCs. The RD-PCR products were
separated by eletrophoresis on 5% polyacrylamide gel and stained
with a silver solution (Figure 3A). Two bands were noticeably
denser compared to the controls. PCR was then performed with
the fragments from the two bands purified from the gel as
templates. After sequencing, one of the fragments was homologous
with TSP-1 by a BLAST search online, and the other was
homologous with another rat gene and will be the subject of future
investigations. Our RT-PCR and Western blot data show that the
TSP-1 gene is up-regulated when BMSCs are co-cultured with
RGCs for 3 days (Figure 3B and 3C). Real-time RT-PCR data
demonstrated that the expression of TSP-1 is up-regulated also
(p=0.037), but TSP-2 gene, another family member, is not
changed, (Figure 3D). The expression of TSP-1 receptors (CD36,
CD47) are up-regulated in RGCs (p=0.012, p=0.014, respec-
tively) (Figure 3D). Additionally, the evidence of TSP-1 up-
regulation is confirmed in co-cultured media by Western blot
analysis (Figure 3E).
Figure 2. The effect of BMSCs on RGCs. A, RGC neurite formation was enhanced after 5 days of co-culturing with BMSCs (106). B,
Synaptophysin, MAP-2 and TGF-b expression were up-regulated in RGCs co-cultured with BMSCs as determined by real-time RT-PCR (p=0.031,
p=0.023, p=0.015, respectively). C, RGC survival was increased when co-cultured with BMSCs (p=0.025) (d) The mean outgrowth of neurites in RGCs
co-cultured with BMSCs increased (p=0.03). *p-values#0.05. (10 pictures were taken randomly under a regular microscope from culturing cells at
different time points. The average relative percent of surviving and outgrowth of RGCs come from at least three separate experiments).
doi:10.1371/journal.pone.0002470.g002
TSP-1, BMSCs, RGCs
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TSP-1 is an extracellular matrix protein critically important in
the formation of neural connections during development. TSP-1 is
expressed at high levels in the early postnatal rat cortex and
superior colliculus, during the period of intense synaptogenesis,
but its expression is reduced in the adult. We sought to determine
whether TSP-1 secreted by BMSCs affects neural cell survival and
neurite outgrowth. In order to answer this question, siRNA
interference was performed to silence TSP-1 expression. Trans-
fection of BMSCs with siRNA oligos using a cationic lipid might
affect expression of other proteins and reduce experimental
reliability. Thus, we also used controls to overcome siRNA
silencing of TSP-1 by transducing BMSCs with a recombinant
adenovirus with a CMV-promoter containing TSP-1 cDNA (pAd/
CMV-Myc-TSP-1). We used a two-time tandem RNA transfec-
tion approach at an interval of 1 day, then transduced BMSCs
with the recombinant adenovirus (pAd/CMV-Myc-TSP-1) ex-
pressing TSP-1, a fusion protein, and Myc-TSP-1, coincident with
the second siRNA transfection. The cells were harvested on the
third day after the first transfection. This protocol produced a
marked reduction in TSP-1 expression. However, TSP-1 expres-
sion was rescued by pAd/CMV-Myc-TSP-1 transduction
(Figure 4, lane 3). Western blot confirmed exogenous TSP-1
expression, which was corroborated by antibody staining for Myc
(Figure 4, lane 6). Of note, a start codon ‘‘ATG’’ is not present
before the Myc epitope in the TSP-1 negative adenoviral vector,
thus antibody stainings for Myc are negative in lanes 4 and 5.
TSP-1 silencing significantly affects BMSC morphology
and inhibits RGC neurite outgrowth, but does not alter
BMSC and RGC survival
Some BMSCs were transfected with siRNA oligos and infected
with a recombinant adenovirus (pAd/CMV-Myc-TSP-1) express-
ing TSP-1 before co-culturing them with RGCs as described
above. Figure 5A shows that BMSCs with TSP-1 silencing with
siRNA have fewer neural-like cells than the control BMSCs (i.e.,
without TSP-1 silencing) co-cultured with RGCs. The reduced
number of neural-like cells is about 2.5-fold lower than control
BMSCs ( p=0.011). The morphology of BMSCs with siRNA
silencing of TSP-1 was normalized to the controls infected with the
recombinant adenovirus expressing TSP-1. Figure 5B shows
quantification of neural-like cells observed with microscopy. After
Figure 3. Patterns of differentially expressed genes in BMSCs. A, 5% polyacrylamide gel eletrophoresis demonstrates two dense bands
representing upregulated genes in BMSCs co-cultured with RGC (white arrowheads). B, RT-PCR using total RNA isolated from BMSCs on day three
demonstrated increased TSP-1 mRNA expression compared to controls. C, BMSC TSP-1 protein expression was increased as compared to the controls
as demonstrated by Western blot. b-actin was used as a loading control in B and C. D, TSP-1, TSP-2 and TSP-1 receptors (CD36, CD47) expression were
determined by real-time RT-PCR. E, Western analysis for TSP-1 in co-culture medium. *p-values#0.05. (All data come from at least three separate
experiments).
doi:10.1371/journal.pone.0002470.g003
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data show that TSP-1 does not affect BMSC survival.
Similarly, Figure 6A shows that BMSCs with TSP-1 silenced
with siRNA do not alter RGC survival, but significantly inhibit
RGC neurite outgrowth. Figure 6B shows quantification of RGC
neurite formation observed with microscopy (106) after 5 days of
co-culturing.
TSP-1 silencing affects the expression of synaptophysin,
MAP-2 and TGF-b in RGCs
TSP-1 helps to promote normal CNS synaptogenesis in vivo and
vitro [50,51]. Synaptophysin is involved in the synapse formation of
RGCs. In order to establish an assay to identify synaptogenic
activities by BMSC-secreted TSP-1, the expression of synaptophysin
in RGCs was assayed by immunohistochemistry and Western blot.
Figure 7A, 7B show that the expression of synaptophysin in RGCs
was up-regulated by co-culturing with BMSCs, and normalized
when RGCs were co-cultured with BMSCs with endogenous TSP-1
silenced. RGC synaptophysin down-regulation was reversed when
co-culturing with BMSCs (with TSP-1 siRNA) that were infected
with the adenoviral vector expressing TSP-1. Additionally, TSP-1
affects MAP-2 and TGF-b, activated by TSP-1. Real-time RT-PCR
data showed that synaptophysin, MAP-2 and TGF-b expression in
RGCs were up-regulated by co-culturing with BMSCs, and
normalized when RGCs were co-cultured with BMSCs with
endogenous TSP-1 silenced (Figure 7C).
Discussion
The BMSCs and RGCs affect each other when co-cultured
in vitro
BMSC differentiation into neural cells is a widely debated
phenomenon [52,53]. BMSCs are multipotent stem cells, which
can differentiate into various cell types depending upon their local
Figure 4. Endogenous TSP-1 expression was silenced by siRNA
and rescued by infection with a recombinant adenovirus
containing the wild-type TSP-1 cDNA driven by the CMV
promoter (pAd/CMV-Myc-TSP-1). (The experiments were repeated
at least three times).
doi:10.1371/journal.pone.0002470.g004
Figure 5. Morphological changes of BMSCs after co-culturing with RGCs when TSP-1 was silenced with siRNA and rescued by
infection with a recombinant adenovirus expressing TPS1. 48 hours after the first siRNA transfection, BMSCs and RGCs were co-cultured in a
transwell system. A, Neural-like morphological changes (106) in BMSCs was increased at 3 and 5 days in controls (1). This effect was diminished when
TSP-1 was silenced with siRNA (2), but restored in BMSCs infected with a TSP-1-expressing adenovirus (3). B, Bar graph shows the mean and SE of the
percentage of neural-like cells in the control, silenced, and rescued BMSCs (p=0.011, p=0.022, p=0.028, respectively). *p-values#0.05. (10 pictures
were taken randomly under a regular microscope from culturing cells at different time points. The average relative percent of neural-like BMSCs come
from at least three separate experiments).
doi:10.1371/journal.pone.0002470.g005
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for over a week, the BMSCs differentiated into cells that exhibited
some morphological characteristics of neural cell lineages, a result
which is not likely achievable with simple chemical treatments. It is
known that BMSCs can progressively assume neural-like mor-
phological characteristics within the first 3 hours when treated
with certain chemicals, such as DMSO, butylated hydroxyanisole,
and isobutylmethylxanthine [17]. However, the mechanism
underlying the induction of neural-like differentiation in BMSCs
in RGC-conditioned medium in our experiments is likely different
from that of chemical treatments because chemical treatments
cause rapid morphological changes and cell death, whereas co-
culturing causes a slower progression of morphological changes
and delayed cell death.
Various factors secreted by RGCs might induce BMSC neural-
like differentiation. For example, Mizobe and our group have
reported that Thy-1.1, NF and MAP-2 expressed by RGCs
accelerates neural-like differentiation in BMSCs [54]. Interesting-
ly, we found in our study that the TSP-1 gene in BMSCs was up-
regulated after co-culturing with RGCs. And real-time RT-PCR
data showed that TSP-1 receptors (CD36, CD47) [55,56] are up-
regulated in RGCs co-cultured with BMSCs. TSP-1 may, in part,
be responsible for the neurite-like outgrowth we observed in
BMSCs. These observations suggest the possibility of using
BMSCs as therapeutic agents in neurological diseases.
Furthermore, BMSCs significantly increased the propensity of
RGCs to form neurites with branching growth cones and yielded
an increased survival compared to controls. RGC survival
increased by approximately 1.7 fold and more than 70% had
intact neurites after 5 days of co-culturing with BMSCs, indicating
that factors secreted by BMSCs may improve RGC survival and
neurite outgrowth. And real-time RT-PCR data showed that
synaptophysin, MAP-2 and TGF-b is up-regulated in RGCs co-
cultured with BMSCs.
Therefore, BMSCs and RGCs seem to affect each other when
co-cultured in vitro through increased expression of various
proteins in both cell types. Likewise, the specific interactions
leading to BMSC neural-like differentiation probably involve
complex interactions with multiple proteins and/or signaling
pathways that will need further elaboration.
TSP-1 is up-regulated in BMSCs co-cultured with RGCs
Why is TSP-1 up-regulated in BMSCs co-cultured with RGCs?
TSP-1 is secreted by a wide variety of epithelial and mesenchymal
cells, in patterns that mirror developmental changes in the embryo
and response to injury in the adult, and is critically important in
the formation of neural connections during development [53,54].
Brain macrophages contribute actively to neurite growth and
regeneration during the development or in pathological states
through the secretion of TSP [57]. After co-culturing with RGCs,
the conditioned medium progressively induced neural-like differ-
entiation in BMSCs. Initially, in the first day of co-culturing, the
cytoplasm in one percent of BMSCs retracted toward the nucleus
and began forming a rounded cell body. During such morpho-
logical changes, cell adhesion occurs in three distinct and
identifiable stages: shrinking, spreading, and attaching. These
stages involve interactions between integrins, along with accessory
receptors such as syndecans, and their extracellular matrix
substrates [58]. Therefore, TSP-1 likely plays a key role when
BMSCs are induced by co-culturing with RGCs to differentiate
into neural-like cells. This supposition is supported by our TSP-1
silencing and rescue experiments. These experiments showed that
TSP-1 silencing reduced BMSC neural-like differentiation in
RGC-conditioned medium; whereas, TSP-1 rescue in BMSCs
Figure 6. Morphological changes of RGCs after co-culturing with BMSCs with the endogenous TSP-1 silenced by siRNA and rescued
by infection with a recombinant adenovirus expressing TSP-1. 48 hours after the first siRNA transfection, BMSCs and RGCs were co-cultured
in a transwell system. A, After 5 days, RGC survival was not diminished by co-culturing with BMSCs with TSP-1 silencing, but the degree of RGC
neurite outgrowth was lessened (3). B, Bar graph shows the mean and SE of RGC neurite outgrowth in within (106) microscopic fields after 5 days of
co-culturing. RGC neurite outgrowth was enhanced by co-culturing with BMSCs (2), which was diminished with TSP-1 silencing (3) but restored in
TSP-1-rescued co-cultures (4) (p=0.038). *p-values#0.05. (10 pictures were taken randomly under a regular microscope from culturing cells at
different time points. The average relative percent of outgrowth of RGCs come from at least three separate experiments).
doi:10.1371/journal.pone.0002470.g006
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effect of siRNA silencing.
Thrombospondin family includes five members (TSP-1, TSP-2,
TSP-3, TSP-4, and TSP-5)[51]. TSP-1 and TSP-2 are distin-
guished from the other three thrombospondins by a further set of
three repeats, originally termed thrombospondin type 1 repeats.
But our experimental data showed that only TSP-1 is up-regulated
in BMSCs co-cultured with RGCs, TSP-2 is kept at the same level.
TSP-1 secreted by BMSCs contributes to RGC neurite
outgrowth and synaptogenesis
Thrombospondins are a family of multimeric, calcium-binding
extracellular glycoproteins. The first identified thrombospondin,
TSP-1, was discovered as a stored protein in a-granules that are
released upon platelet activation. Initial studies of the function of
TSP-1, therefore, focused on its role in platelet aggregation and
fibrin clot formation, and also its effect on vascular endothelial and
smooth muscle cells [59,60]. In recent years, TSP-1 was found
widely distributed in the embryonic extracellular matrix and
expressed at high levels in the developing nervous system.
Especially, in the postnatal but not adult CNS, TSP-1 is broadly
localized in astrocytes and synapses, as expected for an astrocyte-
secreted extracellular matrix molecule [61]. In addition, when
peripheral nerves are damaged, TSP-1 expression is up-regulated
and promotes neural growth and repair [36]. Therefore, the
expression patterns and actions of TSP-1 in vitro suggest its
potential role in the guidance of cell and growth cone migration.
One report has shown that TSP-1 secreted by astrocytes is
necessary and sufficient to induce synapse formation of ultrastruc-
turally normal RGCs in vitro [38]. Mice lacking both TSP-1 genes
have substantially fewer synapses in many CNS regions, indicating
that TSP-1 helps promote normal CNS synaptogenesis in vivo
[38]. Our RT-PCR and Western blot data show that TSP-1 is up-
regulated in BMSCs co-cultured with RGCs. When TSP-1
expression was decreased with siRNA, BMSCs did not affect
RGC survival, but rather reduced neurite outgrowth and the
expression of synaptophysin in RGCs. Synaptophysin was the first
cloned synaptic vesicle (SV) protein. Since its discovery in 1985
[62], synaptophysin has been used by many laboratories around
the world as an invaluable marker to study the distribution of
Figure 7. RGC synaptophysin, MAP-2 and TGF-b expression level were determined with and without BMSC (+/2 TSP-1 siRNA
silencing) co-culturing. BMSCs were transfected with siRNA oligos and infected with a recombinant adenovirus (pAd/CMV-Myc-TSP-1) expressing
TSP-1 before co-culturing as described above. A, After 3 days, immunohistochemical analysis of RGCs for synaptophysin (red dots) shows more
synaptic puncta when co-culturing with BMSCs compared to RGCs alone (2 & 4), but fewer when TSP-1 was silenced by siRNA (3). B, Western blot
shows synaptophysin in RGCs is up-regulated by TSP-1; (2), which was diminished by TSP-1 silencing (3) and restored by TSP-1-expressing adenoviral
rescue (4). C, After 3 days, synaptophysin, MAP-2 and TGF-b expression were determined by real-time RT-PCR (p=0.019, p=0.020, p=0.017,
respectively). *p-values#0.05. (The experiments were repeated at least three times).
doi:10.1371/journal.pone.0002470.g007
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cycle of SVs. Although single gene ablation of synaptophysin does
not lead to an overt phenotype, a large body of experimental data,
both in vitro and in vivo, indicate that synaptophysin (alone or in
association with homologous proteins) is involved in multiple,
important aspects of SV exo-endocytosis, including the regulation
of SNARE (soluble N-ethylmaleimide-sensitive factor attachment
protein receptor) assembly into the fusion core complex, formation
of the fusion pore initiating neurotransmitter release, activation of
SV endocytosis, and SV biogenesis [61,63,64]. Therefore, our
results suggest that TSP-1 secreted by BMSCs plays a key role
during synaptogenesis of RGCs in vitro.
How does TSP-1 induce RGC neurite outgrowth and
synaptogenesis? Real-time RT-PCR data showed that TGF-b,
activated by TSP-1, is up-regulated in RGCs co-cultured with
BMSCs. TGF-b is a multifunctional cytokine with anti-inflamma-
tory, reparative and neuroprotective functions [65-67]. Dhanda-
pani and Brann demonstrated that the lack of TGF-b1 expression
in neonatal TGF-b1( 2/2) mice results in a widespread increase
in degenerating neurons accompanied by prominent microgliosis
and reduced expression of synaptophysin and laminin [68].
Furthermore, TGF-b1 loss also strongly reduces survival of
primary neurons cultured from TGF-b1( 2/2) mice. The authors
suggest that TGF-b1 regulates the expression and ratio of
apoptotic (Bad) and antiapoptotic proteins (Bcl-2, Bcl-61),
creating an environment favorable for cell survival of death-
inducing insults [69]. This evidence strongly suggests the
possibility that TSP-1 may act, in part, by inducing neurons to
alter expression of proteins that participate in synaptogenesis.
In conclusion, we have shown that BMSCs improve RGC
survival and neurite outgrowth. Meanwhile, the RGC-conditioned
medium induces neural-like differentiation in BMSCs. During
differentiation, TSP-1 in BMSCs is up-regulated after co-culturing
with RGCs, and TSP-1 is probably involved in RGC neurite
outgrowth and synaptogenesis. This study provides new insights
into BMSC-mediated reparative mechanisms that might one day
be translated into novel treatments for neurological disorders.
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